<code id='7C5F7AED30'></code><style id='7C5F7AED30'></style>
    • <acronym id='7C5F7AED30'></acronym>
      <center id='7C5F7AED30'><center id='7C5F7AED30'><tfoot id='7C5F7AED30'></tfoot></center><abbr id='7C5F7AED30'><dir id='7C5F7AED30'><tfoot id='7C5F7AED30'></tfoot><noframes id='7C5F7AED30'>

    • <optgroup id='7C5F7AED30'><strike id='7C5F7AED30'><sup id='7C5F7AED30'></sup></strike><code id='7C5F7AED30'></code></optgroup>
        1. <b id='7C5F7AED30'><label id='7C5F7AED30'><select id='7C5F7AED30'><dt id='7C5F7AED30'><span id='7C5F7AED30'></span></dt></select></label></b><u id='7C5F7AED30'></u>
          <i id='7C5F7AED30'><strike id='7C5F7AED30'><tt id='7C5F7AED30'><pre id='7C5F7AED30'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:57
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Prime Medicine says its gene editing passes test in monkeys
          Prime Medicine says its gene editing passes test in monkeys

          DavidLiuproposedprimeeditingofgenesin2019.Thetechnologyhaspassedabigtest.CourtesyErikJacobs/BroadIns

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          The FDA weighs the risks of candy

          AdobeWASHINGTON—M&Ms,Reese’s,gummybears,andevencottoncandymadeanappearanceattheFoodandDrugAdmini